A carregar...
Vasopressin in chronic kidney disease, an elephant in the room?
The report by Perico et al that a dual arginine vasopressin (AVP) V2 and V1a receptor antagonist lowers blood pressure, proteinuria and glomerulosclerosis in 5/6 nephrectomized rats points to a potential therapeutic value of AVP receptor antagonists in the treatment of chronic kidney disease (CKD)....
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2925670/ https://ncbi.nlm.nih.gov/pubmed/19829311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2009.325 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|